United Therapeutics Corp. (UTHR)
473.42
-7.10
(-1.48%)
USD |
NASDAQ |
Feb 20, 16:00
472.79
-0.63
(-0.13%)
After-Hours: 20:00
United Therapeutics Research and Development Expense (Quarterly) : 127.50M for Sept. 30, 2025
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Corcept Therapeutics, Inc. | 68.85M |
| Catalyst Pharmaceuticals, Inc. | 2.657M |
| MannKind Corp. | 14.06M |
| Madrigal Pharmaceuticals, Inc. | 115.88M |
| Vertex Pharmaceuticals, Inc. | 973.70M |